BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading biopharmaceutical company in China, categorically rejects the recent ...

Sinovac Foundation, a subsidiary of China's leading vaccine manufacturer Sinovac Biotech Limited, has donated 3.83 ...

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended ...

Add Yahoo as a preferred source to see more of our stories on Google. People who were originally fully vaccinated with the Chinese-made Sinovac COVID-19 vaccine were shown to develop a high degree of ...

View Sinovac Biotech Ltd. SVA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A medical worker holds a dose of the Sinovac vaccine at a district health facility as Indonesia begins mass ...

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal ...

The Government of Mexico City has decided to increase the rate of vaccination in the city, given that the Delta variant of SARSCov2 has again accelerated the infection and the Capotalinos hospitals ...

BEIJING, Sept 6 (Reuters) - (This September 6 story corrected spelling of Fudan University from Furan in paragraph 5) A booster dose of Sinovac Biotech's (SVA.O), opens new tab COVID-19 vaccine ...

China’s Sinovac claimed that a third dose of its Covid-19 vaccine is 94% effective against the omicron variant of the coronavirus, Nikkei Asia reported, in a statement the comes just a day after a ...

The Sinovac Foundation, a subsidiary of Chinese vaccine manufacturer Sinovac Biotech, has donated 3.8 lakh doses of polio vaccine to Bangladesh's Ministry of Health and Family Welfare to support the ...